241 related articles for article (PubMed ID: 19097864)
1. Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin.
Viale P; Furlanut M; Scudeller L; Pavan F; Negri C; Crapis M; Zamparini E; Zuiani C; Cristini F; Pea F
Int J Antimicrob Agents; 2009 Apr; 33(4):379-82. PubMed ID: 19097864
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation.
Barberán J; Aguilar L; Giménez MJ; Carroquino G; Granizo JJ; Prieto J
Int J Antimicrob Agents; 2008 Aug; 32(2):154-7. PubMed ID: 18571387
[TBL] [Abstract][Full Text] [Related]
3. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections.
Guillaume M; Garraffo R; Bensalem M; Janssen C; Bland S; Gaillat J; Bru JP
Med Mal Infect; 2012 Sep; 42(9):414-20. PubMed ID: 22944286
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute post-surgical infection of joint arthroplasty.
Soriano A; García S; Bori G; Almela M; Gallart X; Macule F; Sierra J; Martínez JA; Suso S; Mensa J
Clin Microbiol Infect; 2006 Sep; 12(9):930-3. PubMed ID: 16882303
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of oral levofloxacin and dirithromycin alone and in combination with rifampicin in the treatment of experimental murine Brucella abortus infection.
Arda B; Tunçel M; Yaimazhan T; Gökengin D; Gürel O
Int J Antimicrob Agents; 2004 Feb; 23(2):204-7. PubMed ID: 15013048
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides.
Blázquez Garrido RM; Espinosa Parra FJ; Alemany Francés L; Ramos Guevara RM; Sánchez-Nieto JM; Segovia Hernández M; Serrano Martínez JA; Huerta FH
Clin Infect Dis; 2005 Mar; 40(6):800-6. PubMed ID: 15736011
[TBL] [Abstract][Full Text] [Related]
8. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.
Tribble DR; Sanders JW; Pang LW; Mason C; Pitarangsi C; Baqar S; Armstrong A; Hshieh P; Fox A; Maley EA; Lebron C; Faix DJ; Lawler JV; Nayak G; Lewis M; Bodhidatta L; Scott DA
Clin Infect Dis; 2007 Feb; 44(3):338-46. PubMed ID: 17205438
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three different combination therapies in the treatment of human brucellosis.
Ersoy Y; Sonmez E; Tevfik MR; But AD
Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
12. Urinary bactericidal activity of single doses (250, 500, 750 and 1000 mg) of levofloxacin against fluoroquinolone-resistant strains of Escherichia coli.
Stein GE; Schooley SL; Nicolau DP
Int J Antimicrob Agents; 2008 Oct; 32(4):320-5. PubMed ID: 18715762
[TBL] [Abstract][Full Text] [Related]
13. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients.
Barberán J; Aguilar L; Carroquino G; Giménez MJ; Sánchez B; Martínez D; Prieto J
Am J Med; 2006 Nov; 119(11):993.e7-10. PubMed ID: 17071171
[TBL] [Abstract][Full Text] [Related]
14. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of prolonged antimicrobial chemotherapy for brucellar spondylodiscitis.
Ioannou S; Karadima D; Pneumaticos S; Athanasiou H; Pontikis J; Zormpala A; Sipsas NV
Clin Microbiol Infect; 2011 May; 17(5):756-62. PubMed ID: 20518794
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC
Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835
[TBL] [Abstract][Full Text] [Related]
17. A comparative analysis of tuberculous, brucellar and pyogenic spontaneous spondylodiscitis patients.
Turunc T; Demiroglu YZ; Uncu H; Colakoglu S; Arslan H
J Infect; 2007 Aug; 55(2):158-63. PubMed ID: 17559939
[TBL] [Abstract][Full Text] [Related]
18. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
Karabay O; Sencan I; Kayas D; Sahin I
BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
[TBL] [Abstract][Full Text] [Related]
19. [Kingella kingae spondylodiscitis in an adult].
Ducoulombier V; Dehecq E; Luraschi H; Prudhomme C; Bessard D; Houvenagel E
Med Mal Infect; 2011 Feb; 41(2):110-2. PubMed ID: 21093187
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia.
Benko R; Matuz M; Doro P; Peto Z; Molnar A; Hajdu E; Nagy E; Gardi J; Soos G
Int J Antimicrob Agents; 2007 Aug; 30(2):162-8. PubMed ID: 17570646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
